Skip to main content
SpringerLink
Log in

Aprotinin: increased risk of death following coronary bypass

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Schneeweiss S, Seeger JD, Landon J, Walker AM.Aprotinin during coronary-artery bypass grafting and risk of death. New England Journal of Medicine 358: 771-783, No. 8, 21 Feb 2008

  2. Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF.The effect of aprotinin on outcome after coronary-artery bypass grafting. New England Journal of Medicine 358: 784-793, No. 8, 21 Feb 2008

  3. Ray WA.Learning from aprotinin - mandatory trials of comparative efficacy and safety needed. New England Journal of Medicine 358: 840-842, No. 8, 21 Feb 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aprotinin: increased risk of death following coronary bypass. React. Wkly. 1191, 3 (2008). https://doi.org/10.2165/00128415-200811910-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811910-00007

Keywords

Search

Navigation